Related Resources

Lauren Neves

Lauren Neves is Vice President of Policy at PhRMA focusing on the value of cancer medicines, medication adherence, and payment and delivery reform. Prior to joining PhRMA, Lauren earned her law degree and worked as a market access and health policy consultant to health care and pharmaceutical clients.

Author Twitter

PhRMA submits comments urging CMS to withdraw coverage proposal

February 11, 2022

5 Ways to improve ICER’s value assessment framework

June 20, 2019

New whitepaper identifies reasons why ICER’s cost-effectiveness analyses are not useful for payers

September 19, 2018

How ICER’s assessment of a new class of migraine treatments fails patients

July 10, 2018

New analysis shows negative impact of ICER’s value framework on patient access in Medicare Part B

May 31, 2018

RA medicines often demonstrate far greater benefits to patients than initially understood

April 5, 2017

How do multiple sclerosis patients define value?

February 24, 2017